📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Inocras

1.1 - Company Overview

Inocras Logo

Inocras

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of whole genome sequencing-based diagnostics and services for cancer and rare diseases, leveraging AI. Offers CancerVision for solid tumors to deliver comprehensive genomic insights, identify actionable treatments, and support clinical trial matching; RareVision for rare disease diagnosis and treatment planning; and sequencing, analytics, automated bioinformatics pipelines, and expert advisory support for clinical and research use.

Products and services

  • CancerVision: A whole-genome sequencing test for cancer patients that produces comprehensive genomic insights, enabling treatment decision-making and matching patients to relevant clinical trials by identifying actionable treatment options
  • RareVision: A whole-genome diagnostic test for rare diseases that offers extensive analysis to identify disease-associated genes and deliver detailed genetic insights for accurate diagnosis and treatment planning
  • Whole Genome Sequencing Services: Supplies clinical and research whole-genome sequencing using advanced platforms and automated bioinformatics pipelines, delivering sequencing outputs and bioinformatics analyses tailored to clinical and research applications

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Inocras

Qpid Health Logo

Qpid Health

HQ: United States Website
  • Description: Provider of clinical insights software that activates clinical intelligence from EHRs and other back-end repositories. Built on the QPID platform, originally developed at Massachusetts General Hospital to help clinicians get value from patient information stored in electronic health records.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Qpid Health company profile →
Renalytix Logo

Renalytix

HQ: United Kingdom Website
  • Description: Provider of AI-enabled clinical diagnostic solutions for kidney disease, improving risk assessment, clinical care, and patient stratification. Offers KidneyIntelX, a platform to assess risk of progressive decline in diabetic kidney disease; KidneyIntelX.dkd, an FDA-authorized test predicting risk in adults with type 2 diabetes and early-stage chronic kidney disease; and Well Filtered insights via blog, webinar, and podcast series.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Renalytix company profile →
1upHealth Logo

1upHealth

HQ: United States Website
  • Description: Provider of a healthcare data platform that aggregates and shares medical data for patients, providers, and software developers. Offers the 1up FHIR Platform to convert data to FHIR for acquisition, management, sharing, and analysis, plus Patient Connect, Population Connect, and APIs for payer-to-payer data exchange, provider access, and patient access to member health records.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 1upHealth company profile →
Get Well Logo

Get Well

HQ: United States Website
  • Description: Provider of patient engagement solutions for healthcare providers, including Get Well 360 for targeted outreach, automated scheduling, and multimodal room tech; interactive patient care via digital rounding, EHR automation, and digital displays; 300+ digital care plans with virtual monitoring; SDOH screening/navigation; ED engagement with smart triage, wait time updates, and admin automation; and AI-enabled care navigator services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Get Well company profile →
Tebra Logo

Tebra

HQ: United States Website
  • Description: Provider of a practice growth solution for healthcare providers, automating touchpoints from online discovery to post-appointment follow-up. Services include SEO-optimized websites, search marketing, online reputation and social media; online scheduling, reminders, digital intake, secure messaging; cloud-based EHR with clinical notes, ePrescribing, eLabs, quality reporting, secure patient portal; billing automation and payments; and analytics for growth, revenue, and operations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tebra company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Inocras

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Inocras

2.2 - Growth funds investing in similar companies to Inocras

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Inocras

4.2 - Public trading comparable groups for Inocras

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Inocras

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Inocras

What does Inocras do?

Inocras is a provider of whole genome sequencing-based diagnostics and services for cancer and rare diseases, leveraging AI. Offers CancerVision for solid tumors to deliver comprehensive genomic insights, identify actionable treatments, and support clinical trial matching; RareVision for rare disease diagnosis and treatment planning; and sequencing, analytics, automated bioinformatics pipelines, and expert advisory support for clinical and research use.

Who are Inocras's competitors?

Inocras's competitors and similar companies include Qpid Health, Renalytix, 1upHealth, Get Well, and Tebra.

Where is Inocras headquartered?

Inocras is headquartered in United States.

How many employees does Inocras have?

Inocras has 1,000 employees 🔒.

When was Inocras founded?

Inocras was founded in 2010 🔒.

What sector and industry vertical is Inocras in?

Inocras is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Inocras

Who are the top strategic acquirers in Inocras's sector and industry

Top strategic M&A buyers and acquirers in Inocras's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Inocras?

Top strategic M&A buyers groups and sectors for Inocras include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Inocras's sector and industry vertical

Which are the top PE firms investing in Inocras's sector and industry vertical?

Top PE firms investing in Inocras's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Inocras's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Inocras's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Inocras's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Inocras include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Inocras's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Inocras?

The key public trading comparables and valuation benchmarks for Inocras include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Inocras for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Inocras with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Inocras's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Inocras with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Inocras's' sector and industry vertical?

Access recent funding rounds and capital raises in Inocras's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Inocras